136 related articles for article (PubMed ID: 7664171)
21. Dual TLR2/9 Recognition of Herpes Simplex Virus Infection Is Required for Recruitment and Activation of Monocytes and NK Cells and Restriction of Viral Dissemination to the Central Nervous System.
Uyangaa E; Choi JY; Patil AM; Hossain FMA; Park SO; Kim B; Kim K; Eo SK
Front Immunol; 2018; 9():905. PubMed ID: 29760708
[TBL] [Abstract][Full Text] [Related]
22. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
Hayashi K; Hayashi T; Miyazawa K; Tomoda A
J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
[TBL] [Abstract][Full Text] [Related]
23. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
[TBL] [Abstract][Full Text] [Related]
24. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
25. Effects of selective depletion of L3T4+ T-lymphocytes on herpes simplex virus encephalitis.
Erlich KS; Wofsy D; Dix RD; Mills J
Clin Immunol Immunopathol; 1989 Aug; 52(2):190-201. PubMed ID: 2525439
[TBL] [Abstract][Full Text] [Related]
26. Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response.
Rogers D; Vila-Leahey A; Pessôa AC; Oldford S; Marignani PA; Marshall JS
Front Immunol; 2018; 9():1894. PubMed ID: 30158936
[TBL] [Abstract][Full Text] [Related]
27. [Antiviral and anti-stress activity of the gamma-L-glutamyl-histamine and its derivatives].
Nosik NN; Nebol'sin VE; Zheltukhina GA; Evstigneeva RP; Kondrashina NG; Lavrukhina LA; Krzhechkovskaia VV
Vopr Virusol; 2003; 48(1):38-42. PubMed ID: 12608061
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
29. A NK complex-linked locus restricts the spread of herpes simplex virus type 1 in the brains of C57BL/6 mice.
Kastrukoff LF; Lau AS; Takei F; Carbone FR; Scalzo AA
Immunol Cell Biol; 2015 Nov; 93(10):877-84. PubMed ID: 25971711
[TBL] [Abstract][Full Text] [Related]
30. Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody.
Ching C; Lopez C
Infect Immun; 1979 Oct; 26(1):49-56. PubMed ID: 227799
[TBL] [Abstract][Full Text] [Related]
31. The effect of cimetidine on survival of mice infected with herpes simplex virus type 2, murine encephalomyelitis virus and vesicular stomatitis virus infections.
Kabuta H; Yamamoto S; Shingu M
Kurume Med J; 1989; 36(3):95-9. PubMed ID: 2561403
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice.
Bukowski JF; Woda BA; Welsh RM
J Virol; 1984 Oct; 52(1):119-28. PubMed ID: 6207307
[TBL] [Abstract][Full Text] [Related]
33. NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites.
Brune M; Hansson M; Mellqvist UH; Hermodsson S; Hellstrand K
Eur J Haematol; 1996 Oct; 57(4):312-9. PubMed ID: 8982295
[TBL] [Abstract][Full Text] [Related]
34. Experimental infection of inbred mice with herpes simplex virus. II. Interferon production and activation of natural killer cells in the peritoneal exudate.
Engler H; Zawatzky R; Goldbach A; Schröder CH; Weyand C; Hämmerling GJ; Kirchner H
J Gen Virol; 1981 Jul; 55(Pt 1):25-30. PubMed ID: 6170726
[TBL] [Abstract][Full Text] [Related]
35. Histaminergic regulation of antibody-dependent cellular cytotoxicity of granulocytes, monocytes, and natural killer cells.
Hellstrand K; Asea A; Hermodsson S
J Leukoc Biol; 1994 Mar; 55(3):392-7. PubMed ID: 8120456
[TBL] [Abstract][Full Text] [Related]
36. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1.
Brandt CR; Salkowski CA
Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):113-20. PubMed ID: 1370438
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of recognition of herpes simplex virus type 1-infected cells by natural killer cells.
López-Guerrero JA; Alarcón B; Fresno M
J Gen Virol; 1988 Nov; 69 ( Pt 11)():2859-68. PubMed ID: 2846762
[TBL] [Abstract][Full Text] [Related]
38. Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine.
Harrison CJ; Miller RL; Bernstein DI
Vaccine; 2001 Feb; 19(13-14):1820-6. PubMed ID: 11166907
[TBL] [Abstract][Full Text] [Related]
39. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
